FILE NAME: Asbestos International Association (AINT) DATE: 1997 Nov 10 DOC#: AINT016 DOCUMENT DESCRIPTION: Submission to the Social, Health and Family Affairs Committee ofthe Council of Europe from the AINT European Advisory Council [Note - Many originals are on legal size paper so text looks small when reprinted on 8.5x11 paper] The Asbestos .ntemanonat Association fo, envitonmen^l and oco protection wherever asbestos or other fibres are used for the same purposes EUROPEAN ADVISORY COUNCIL OF THE A.I.

Water samples are periodically analyzed for total bacterial counts and for the presence o f coliforms, lead, and other contaminants.

Match considerably in the lead.

ADDITIONAL INFORMATION RELEVANT TO CARCINOGENESIS OR POSSIBLE MECHANISMS OF CARCINOGENESIS RCS deposited in the lungs causes epithelial injury and macrophage activation, leading to inflammatory responses and cell proliferation of the epithelial and interstitial cells.

Water samples are periodically analyzed for total bacterial counts and for the presence ofcoliforms, lead, and other contaminants.

MATERIAL IDENTIFICATION Name: Leaded Regular Gasoline Conoco Product Code: 1100 Synonyms: Automotive Leaded Gasoline Chemical Family: Mixed Petroleum Hydrocarbons Manufacturer: Conoco Inc.

A mm m Vinyl W m Institute A Division of The Society of The Plastics Industry, Inc.

P'l ^'o Q J B)ji l)m g IU THE CIRCUIT COURT OF THE COUNTY OF ST.

Leading VS. manufacturer of industrial asphalt and oneof dieleadingproducers inthe worid.

Mack Trucks further objects to requests where the matter sought is neither relevant to the subject matter involved in the pending action nor reasonably calculated to lead to the discovery of admissible evidence.

INDEX OF SHOPS AND OPERATIONS Name- Barrel and Grease Plant Boiler Shop Car Shop Carpenter Shop Central Shop Electrical Shop Instrument Shop Laboratory Labor Section Lead Burning Loading Racks Machine Shop Mason Shop Paint Shop Pipe Shop Process Control Laboratories Processing Rigging Section Storehouse Transportation Welding Shop Wharf Sect: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 On tr o rwv 035M2 5 P\J /KVj r ossoea f BARREL AND GREASE PLANT 1.

CHEMICAL MANUFACTURERS ASSOCIATION July 5, 1994 JIJL 5 Dear Vinyl Chloride Research Coordinators: The following items are enclosed: 1) the agenda for the August 2, 1994 VCRC meeting; 2) the June 13, 1994 Record of Conference Call; 3) the July 5, 1994 letter to EPA requesting a meeting with the Agency to discuss Richard Reitz's pharmacokinetic risk assessment model for vinyl chloride; 4) a list of ATSDR chemicals added to EPA's Master Testing List under TSCA Section 4.

BUSINESS CORPORATE SNAPSHOT; THE GEON CO.

LIFT ONE LEAD TO INPUT CONVERTER 2067B.

Cancer Mortality, by State--1994 ....................................................... 2 4 4 5 6 7 8 SELECTED CANCERS........................................................................... 9 Lung Cancer............................................................................................ 9 Colon and Rectum Cancer..................................................................... 9 Breast Cancer............................................................................................10 Prostate Cancer........................................................................................ 10 Leading Sites of Cancer Incidence and Death--1994 Estimates................................................................................................ 11 How to Estimate Cancer Statistics Locally..........................................12 Pancreas Cancer....................................................................................... 12 Uterus (Cervix) Cancer............................................................................ 12 Percentage of Population (Probability) Developing Invasive Cancers at Certain Ages........................................................13 Uterus (Endometrial) Cancer.................................................................. 13 Cancer in Children................................................................................... 13 Leukemia................................................................................................... 14 Lymphoma.................................................................................................14 Tables are indicated in bold print.